BVF PARTNERS L P/IL
SEC Form 4 insider trading activity
BVF PARTNERS L P/IL has filed 3 SEC Form 4 filings (11 transaction rows) across 3 companies, including KYMR, XOMA, MLTX, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Jun 26, 2026.
On the most recent filing, BVF PARTNERS L P/IL is listed as Director at Kymera Therapeutics, Inc. Inside the rolling window, BVF PARTNERS L P/IL reported no open-market purchases and 2 open-market sales totaling $236.6M in KYMR and MLTX. The largest disclosed transaction in the window is a sale of 1,630,658 KYMR shares on Jun 26, 2026, worth $173.7M.
Companies traded
Other insiders at KYMR
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$236.6M
reported sales (SEC code S)
Companies
3
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has BVF PARTNERS L P/IL made?
BVF PARTNERS L P/IL has filed 3 SEC Form 4 filings (11 transaction rows) across 3 companies, including KYMR, XOMA, MLTX since 2026.
Which companies does BVF PARTNERS L P/IL trade?
BVF PARTNERS L P/IL has filed SEC Form 4 disclosures for 3 companies, including KYMR, XOMA, MLTX.
When was BVF PARTNERS L P/IL's most recent SEC Form 4 filing?
BVF PARTNERS L P/IL's most recent SEC Form 4 filing on Tracefour is dated Jun 26, 2026.
What is BVF PARTNERS L P/IL's total buy and sell value in the current window?
Inside the rolling retention window, BVF PARTNERS L P/IL bought $0 and sold $236.6M based on SEC Form 4 filings.
What was BVF PARTNERS L P/IL's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 1,630,658 KYMR shares on 2026-06-26, worth $173.7M, per SEC Form 4 filings.